gliclazide and glyburide

gliclazide has been researched along with glyburide in 158 studies

Research

Studies (158)

Timeframe	Studies, this research(%)	All Research%
pre-1990	20 (12.66)	18.7374
1990's	43 (27.22)	18.2507
2000's	56 (35.44)	29.6817
2010's	32 (20.25)	24.3611
2020's	7 (4.43)	2.80

Authors

Authors	Studies
Ahmad, P; Kumar, A; Pathak, SR; Ray, S; Srivastava, AK; Tewari, P	1
Chander, R; Chaturvedi, D; Ray, S; Srivastava, AK	1
Ahmad, P; Kumar, A; Maurya, RA; Singh, AB; Srivastava, AK	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
Ahmad, P; Kumar, A; Maurya, RA; Sharma, S; Singh, AB; Srivastava, AK; Tamrakar, AK	1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Jackson, WP; Jacobs, P; Kernoff, L; Klaff, LJ; Malan, E; Vinik, AI	1
Dubecz, E; Pogátsa, G	1
De Vigan, C; Delporte, MP; Perrault, M; Thomas, M	1
Balabolkin, MI; Danilova, TI; Ol'shanskaia, AA; Timofeev, AV; Zhuleva, LIu	1
Ambrosi, F; Cristallini, S; Filipponi, P; Gregorio, F; Pedetti, M; Santeusanio, F	1
Friedberg, SJ; Pugh, JA; Ramirez, G; Sawyer, J; Tuley, M; Wagner, ML	1
Nakano, S; Naruto, S; Noguchi, H; Tomita, N	1
Kume, S; Ozaki, Y; Yatomi, Y	1
Harrower, AD	2
Aranyi, Z; Ballagi-Pordány, G; Koltai, MZ; Köszeghy, A; Pogátsa, G	1
Katsumata, K; Katsumata, Y	1
Boutagy, JS; Shenfield, GM; Webb, C	1
Doi, K	1
Harrower, AD; Wong, C	1
Brasseur, R; Deleers, M	1
Godfrey, H; Jerums, G; Larkins, RG; Martin, TJ; Smith, IL; Taft, JL	1
Caravaggio, V; Cortinovis, A; Crippa, A; Crippa, M; Sciacca, V	1
Barnett, AH; Florkowski, CM; Jennings, PE; Jones, AF; Le Guen, C; Lunec, J; O'Donnell, MJ; Richardson, MR	1
Balabolkin, MI; Nedosugova, LV	1
Malaisse, WJ; Malaisse-Lagae, F; Mathias, PC; Sener, A	1
Hatao, K; Kaku, K; Kaneko, T; Matsuda, M; Tsuchiya, M	1
Furman, BL; Musbah, MO	1
Chan, TK; Chan, V; Teng, CS; Yeung, RT	1
Deleers, M; Gelbcke, M; Malaisse, WJ	2
Baba, S; Fukui, I; Goto, Y; Maezawa, H; Nakagawa, S; Sakamoto, N; Takebe, K; Takeda, R	1
Abe, M; Ikeda, Y; Minami, N	1
Frolova, AI; Saltykov, BB; Shubina, IO; Velikov, VK	1
Jackson, WP; Jacobs, P; Kernoff, L; Klaff, LJ; Vinik, AI	1
Enzmann, F; Gastpar, H; Weissgerber, PW; Zoltobrocki, M	1
Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW	1
Akkan, AG; Malaisse, WJ; Sener, A	1
Abiru, N; Akazawa, S; Ishibasi, M; Kawasaki, E; Matsumoto, K; Matsuo, H; Uotani, S; Yamamoto, H; Yamasaki, H; Yano, M	1
Fantus, IG; Klip, A; Leiter, LA; Ramlal, T; Tsiani, E	1
Jennings, PE	1
Bravo, G; Dawson, K; Meneilly, GS; Tessier, D; Tétrault, JP	1
Balabolkin, MI; Maksumova, MA; Orekhov, AN; Slavina, ES; Sobenin, IA	1
Inoue, S; Kobayashi, M; Koizumi, T; Ohnota, H; Sato, F; Tsutsumi, N	1
Kruseman, AC; Menheere, PP; Müller, PG; Nijst, L; Sels, JP; Wolffenbuttel, BH	1
Katsumata, K; Katsumata, Y; Ozawa, T	1
König, E; Limmer, J; Rupprecht, E	1
Akaoka, L; Funato, H; Kawasaki, T; Miyashita, H; Ogata, N; Sekino, N; Tagaya, T; Yamanouchi, T	1
Gross, AS; Rieutord, A; Shenfield, GM; Stupans, I	1
Geisen, K; Krause, E; Papp, JG; Végh, A	1
Selvaag, E	1
Gagliardino, JJ; García, ME; Rossi, PF	1
Delaey, C; Van de Voorde, J	1
Mori, A; Noda, Y; Packer, L	1
Abenhaim, L; Monette, J; van Staa, T	1
Ambrosi, F; Filipponi, P; Gregorio, F; Manfrini, S; Santucci, A	1
Desfaits, AC; Renier, G; Serri, O	2
Koyama, H; Mori, S; Nakajima, K; Sugioka, N; Uno, A	1
Kaneko, T; Sakamoto, N	1
Luo, M; O'Brien, RC	1
Bouskela, E; Conde, CM; Cyrino, FZ; Garcia, AA	1
Bataille, D; Blache, P; Gros, L; Salazar, G; Virsolvy, A	1
Furman, BL; Tanira, MO	1
Fukuzawa, M; Ikehata, F; Miyaguchi, S; Nakazawa, T; Ohta, S; Qiang, X; Sakata, Y; Satoh, J; Toyota, T	1
Courtois, P; Herbaut, C; Malaisse, WJ; Sener, A; Turc, A	1
Ambrosi, F; Carle, F; Filipponi, P; Gregorio, F; Manfrini, S; Merante, D; Testa, R; Velussi, M	1
Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH	1
Cossins, E; Mori, A; Noda, Y; Packer, L	1
Belch, JJ; Jennings, PE	2
de Smet, PA; Fischer, HR	1
Heine, RJ; van der Wal, PS	1
Brunelli, C; Cordera, R; Cordone, S; Olivotti, L; Rossettin, P; Schiavo, M; Spallarossa, P	1
Iwamoto, Y; Ohta, M; Wasada, T; Yano, T; Yui, N	1
Chugh, K; Chugh, SN; Dhawan, R; Kishore, K; Sharma, A	1
Ashcroft, SJ; Mikhailov, MV; Mikhailova, EA	1
Cassone-Faldetta, M; De Luca, O; De Mattia, G; Fava, D; Ghiselli, A; Laurenti, O	1
Abe, Y; Matsumoto, K; Miyake, S; Sera, Y; Tominaga, T; Ueki, Y	1
Farouque, HM; Meredith, IT	1
Auclair, J; Bouskela, E; Félétou, M; Levens, N; Néliat, G; Ravel, D	1
Chow, WH; Davies, C; Jiang, J; Li, GW; Pan, CY; Shi, HL; Sun, XC; Tian, H; Yang, WY; Zhu, XX	1
Antić, S; Bogicević, M; Milojković, M; Mitić-Zlatković, M; Stefanović, V; Stojiljković, S; Vlahović, P	1
Fujita, T; Goto, A; Onozato, ML; Tojo, A	1
Abe, Y; Matsumoto, K; Miyake, S; Sera, Y; Tominaga, T; Yeki, Y	1
Crawford, BA; Perera, C	1
Maddock, HL; Siedlecka, SM; Yellon, DM	1
Bae, JH; Cho, CH; Han, J; Jang, BC; Kim, SP; Kim, SS; Lee, HY; Lim, JG; Park, JW; Park, MJ; Song, DK; Suh, SI; Yun, JE	1
Hayaishi-Okano, R; Hori, M; Kaneto, H; Katakami, N; Kosugi, K; Matsuhisa, M; Ohtoshi, K; Yamasaki, Y	1
Boes, U; Wascher, TC	1
Aburuz, S; McElnay, J; Millership, J	1
Fowler, A; Galiñanes, M; Loubani, M; Standen, NB	1
Awata, T; Inukai, K; Kashiwabara, H; Katayama, S; Kurihara, S; Nakashima, Y; Sawa, T; Suzuki, M; Takata, N; Tanaka, M; Watanabe, M; Yokota, K	1
Hinokio, Y; Hirai, M; Ishihara, H; Katagiri, H; Oka, Y; Satoh, J; Suzuki, S; Takahashi, K; Takizawa, Y; Tsuji, I	1
Harata, N; Kinukawa, J; Shimura, M; Tamai, M	1
Kardas, P	1
Choudhury, H; Harisudhan, T; Mullangi, R; Srinivas, NR; Venkatesh, P	1
Chang, NC; Huang, CL; Lee, TM; Lin, MS; Pan, NH	1
Boggi, U; Bugliani, M; Del Chiaro, M; Del Guerra, S; Del Prato, S; Grupillo, M; Lupi, R; Marchetti, P; Masini, M; Mosca, F; Torri, S; Vistoli, F	1
Chalikias, G; Floros, D; Hatseras, D; Kortsaris, A; Maltezos, E; Papadopoulou, E; Papanas, N; Souliou, E; Symeonidis, G; Trypsianis, G; Tziakas, D	1
Aishima, M; Ito, Y; Naito, S; Nakano, T; Seki, N; Sueishi, K; Teramoto, N; Tomoda, T; Yonemitsu, Y; Yunoki, T	1
Buithieu, J; Mamputu, JC; Räkel, A; Renier, G; Roussin, A; Serri, O	1
Balzi, D; Barchielli, A; Buiatti, E; Lamanna, C; Mannucci, E; Marchionni, N; Masotti, G; Monami, M	1
Jin, SH; Li, ZR; Shi, YQ; Yao, J	1
Kimura, T; Kita, M; Suzuma, K; Takagi, H; Watanabe, D; Yoshimura, N	1
Bilinska, M; Korzeniowska-Kubacka, I; Piotrowicz, R; Potocka, J	1
Ishida, H; Kimoto, K; Kizaki, T; Miyazawa, N; Nakano, N; Ohno, H; Sakurai, T; Suzuki, K; Takahashi, K; Takahashi, M	1
Li, J; Wang, L; Wu, GT; Zhu, WZ	1
Gupta, A; Jain, S; Kumar, N; Tiwary, AK	1
Fujii, M; Inoguchi, T; Kobayashi, K; Maeda, Y; Morinaga, H; Nomura, M; Sasaki, S; Sawada, F; Takayanagi, R; Tsubouchi, H	1
Futami-Suda, S; Kigawa, Y; Nakano, H; Norose, J; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K; Yasuoka, H	1
Balzi, D; Lamanna, C; Mannucci, E; Marchionni, N; Monami, M	1
Argaud, L; Couture-Lepetit, E; Garrier, O; Gateau-Roesch, O; Gomez, L; Loufouat, J; Ovize, M; Robert, D	1
Hayakawa, M; Matsuyama-Yokono, A; Nakano, R; Shibasaki, M; Shiraki, K; Someya, Y; Tahara, A	1
Boggi, U; Bugliani, M; D'Aleo, V; Del Guerra, S; Filipponi, F; Lupi, R; Marchetti, P; Masini, M	1
Khalangot, M; Kovtun, V; Kravchenko, V; Tronko, M	1
Ee, JW; Kwon, SW; Lee, J; Lee, WJ; Park, JH; Shaodong, J	1
Hamaguchi, T; Hasegawa, Y; Ishikawa, T; Kakishita, E; Katsuno, T; Kohri, K; Konya, H; Miuchi, M; Miyagawa, J; Namba, M; Satani, K; Suehiro, A; Umehara, A	1
Arai, K; Hirao, K; Kanamori, A; Matoba, K; Matsuba, I; Mori, H; Takai, M; Takeda, H; Terauchi, Y; Yamauchi, M	1
Chan, JC; Chow, CC; Ko, GT; Kong, AP; Luk, AO; Ma, RC; Ng, VW; Ozaki, R; So, WY; Tong, PC; Yang, X; Yu, LW	1
Buhl, ES; Bøtker, HE; Flyvbjerg, A; Kristiansen, SB; Løfgren, B; Nielsen, JM; Nielsen, TT; Nielsen-Kudsk, JE; Rungby, J; Støttrup, NB	1
Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH	1
Fatehi, M; Lang, VY; Light, PE	1
Lim, PC; Lim, SL; Oiyammaal, C	1
Dyrskjøt, L; Grimm, D; Magnusson, NE; Pietsch, J; Rungby, J; Wehland, M	1
Gomes, T; Juurlink, DN; Mamdani, MM; Shah, BR	1
Binz, TM; Neels, H; Schneider, S; Villani, N	1
Bo, S; Castiglione, A; Cavallo-Perin, P; Ciccone, G; Durazzo, M; Gentile, L; Ghigo, E	1
Kimura, H; Masuda, S; Sato, D; Sato, Y	1
Abdelmoneim, AS; Eurich, DT; Gamble, JM; Johnson, JA; Qiu, W; Seubert, JM; Simpson, SH	1
Khalangot, M; Kovtun, V	1
Buranphalin, S; Doomkaew, A; Prapatpong, P; Suntornsuk, L; Vander Heyden, Y	1
Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A	1
Abdelmoneim, AS; Huang, Y; Light, P; Qiu, W; Simpson, SH	1
Clemens, KK; Dixon, SN; Fleet, JL; Garg, AX; Hramiak, I; McArthur, E	1
Chan, SP; Colagiuri, S	1
Abdelmoneim, AS; Eurich, DT; Qiu, W; Senthilselvan, A; Simpson, SH	1
Feng, YG; Fu, XH; Jiang, ZA; Li, LH; Li, LZ; Zheng, M	1
Ashcroft, FM; Haythorne, E; Kramer, H; Proks, P	1
Dong, J; Liao, L; Shen, X; Xie, T; Xu, C; Zhang, R; Zhou, X; Zou, Z	1
Cordiner, RLM; Pearson, ER	1
Huang, HK; Yeh, JI	1
Bell, C; Shah, AJ; Singh, A; Zhao, K	1
Ramazani, Z; Rashidi, H; Saberi, A; Saberi, M	1
Hage, DS; Li, Z; Matsuda, R; Rodriguez, EL; Sun, Z; Tao, P; Woolfork, AG	1
Chiriac, FL; Iancu, VI; Radu, GL; Scutariu, RE	1
Hussain, F; Khan, M; Parvez, M	1
Gayakvad, B; Kothari, C; Patel, C; Patel, R; Solanki, R; Wadhwana, P	1
Bakulin, DA; Ivanova, OV; Kolosov, YA; Krysanov, IS; Kudrin, RA; Kurkin, DV; Makarova, EV; Robertus, AI	1
Hiley, CR; White, R	1
Fujiwara, H; Hashikawa-Hobara, N; Kawasaki, H; Kitamura, Y; Makino, K; Takatori, S; Wake, Y; Zamami, Y	1

Reviews

7 review(s) available for gliclazide and glyburide

Article	Year
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis. Diabetes care, 1992, Volume: 15, Issue:8 Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States	1992
Sulfonylureas and platelet function. The American journal of medicine, 1981, Volume: 70, Issue:3 Topics: Adenosine Diphosphate; Blood Glucose; Blood Platelets; Collagen; Diabetes Mellitus; Diabetic Angiopathies; Epinephrine; Gliclazide; Glyburide; Humans; Platelet Aggregation; Sulfonylurea Compounds	1981
[Clinical efficacy of glimepiride]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Sulfonylurea Compounds; Vascular Resistance	1997
[Timing of administration of sulfonyl urea derivatives]. Nederlands tijdschrift voor geneeskunde, 2000, Jun-17, Volume: 144, Issue:25 Topics: Biological Availability; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Tolbutamide	2000
Variations in tissue selectivity amongst insulin secretagogues: a systematic review. Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:2 Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide	2012
Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents. Diabetes research and clinical practice, 2015, Volume: 110, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Metformin; Middle Aged; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Treatment Outcome; Young Adult	2015
Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving? Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:4 Topics: Diabetes Mellitus; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glucagon-Like Peptide-1 Receptor; Glyburide; History, 20th Century; History, 21st Century; Humans; Hypoglycemic Agents; Insulin Secretion; Insulin-Secreting Cells; Metformin; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Treatment Failure	2019

Trials

35 trial(s) available for gliclazide and glyburide

Article	Year
Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Aug-18, Volume: 56, Issue:7 Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Female; Gliclazide; Glyburide; Humans; Male; Middle Aged; Platelet Aggregation; Sulfonylurea Compounds	1979
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis. Diabetes care, 1992, Volume: 15, Issue:8 Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; MEDLINE; Meta-Analysis as Topic; Middle Aged; Periodicals as Topic; Sulfonylurea Compounds; Tolazamide; Treatment Outcome; United States	1992
Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM. Diabetes research and clinical practice, 1991, Volume: 14 Suppl 2 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Tolbutamide	1991
Comparison of secondary failure rate between three second generation sulphonylureas. Diabetes research (Edinburgh, Scotland), 1990, Volume: 13, Issue:1 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Random Allocation	1990
Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study. Diabetes research and clinical practice, 1988, Jan-07, Volume: 4, Issue:2 Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Gliclazide; Glyburide; Humans; Platelet Aggregation; Random Allocation; Sulfonylurea Compounds	1988
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas. Current medical research and opinion, 1985, Volume: 9, Issue:10 Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Random Allocation; Sulfonylurea Compounds	1985
[Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1982, May-13, Volume: 58, Issue:19 Topics: Blood Glucose; Diabetic Retinopathy; Fibrinolysis; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Middle Aged; Platelet Aggregation; Sulfonylurea Compounds	1982
Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes. The Tohoku journal of experimental medicine, 1983, Volume: 141 Suppl Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Female; Fundus Oculi; Gliclazide; Glyburide; Humans; Lipids; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Random Allocation; Sulfonylurea Compounds	1983
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes care, 1995, Volume: 18, Issue:3 Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides	1995
Insulin response after treatment depends on fasting plasma glucose level in NIDDM. Diabetes research and clinical practice, 1994, Dec-16, Volume: 26, Issue:2 Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Fasting; Female; Gliclazide; Glucagon; Glucose Tolerance Test; Glyburide; Humans; Insulin; Male; Middle Aged	1994
The potential of gliclazide, a sulphonylurea to influence the oxidative processes within the pathogenesis of diabetic vascular disease. Advances in experimental medicine and biology, 1994, Volume: 366 Topics: Adult; Aged; Analysis of Variance; Animals; Blood Glucose; Diabetic Angiopathies; Free Radical Scavengers; Gliclazide; Glyburide; Glycated Hemoglobin; Glycosylation; Humans; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Platelet Aggregation; Protein Processing, Post-Translational; Serum Albumin; Superoxide Dismutase	1994
Glibenclamide vs gliclazide in type 2 diabetes of the elderly. Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:10 Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; Humans; Hypoglycemia; Male	1994
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM. European journal of clinical pharmacology, 1993, Volume: 45, Issue:2 Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Piperidines; Tolbutamide	1993
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet (London, England), 1996, Jun-01, Volume: 347, Issue:9014 Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Time Factors	1996
Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study. Diabetes research and clinical practice, 1997, Volume: 37, Issue:1 Topics: Blood Glucose; Body Constitution; Body Mass Index; C-Peptide; Cholesterol; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Fatty Acids, Nonesterified; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipoprotein(a); Male; Metformin; Middle Aged; Regression Analysis; Sex Characteristics	1997
Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin. Diabetic medicine : a journal of the British Diabetic Association, 1999, Volume: 16, Issue:12 Topics: Aged; Aging; Antithrombin III; Blood Glucose; Blood Platelets; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fibrinolysis; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Thrombin	1999
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients. Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:1 Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides	2000
Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide. Metabolism: clinical and experimental, 2000, Volume: 49, Issue:2 Suppl 1 Topics: Adult; Aged; Blood Platelets; Collagen; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Free Radical Scavengers; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Oxidation-Reduction; Sulfonylurea Compounds	2000
Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide. Diabetes research and clinical practice, 2001, Volume: 52, Issue:2 Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Reference Values; Sulfonylurea Compounds	2001
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia. Diabetes care, 2001, Volume: 24, Issue:4 Topics: Aged; Aged, 80 and over; Blood Pressure; Brachial Artery; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Forearm; Gliclazide; Glyburide; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ischemia; Male; Metformin; Middle Aged; Reference Values; Regional Blood Flow; Sulfonylurea Compounds; Ultrasonography	2001
[Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide]. Terapevticheskii arkhiv, 2001, Volume: 73, Issue:4 Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Follow-Up Studies; Free Radical Scavengers; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Lipid Peroxidation; Male; Middle Aged; Myocardial Ischemia; Oxidative Stress; Time Factors	2001
Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study. The Journal of the Association of Physicians of India, 2001, Volume: 49 Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Oxidative Stress	2001
Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:9 Topics: Adult; Aged; Antioxidants; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Free Radicals; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Injections, Intravenous; Lipid Peroxides; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Vasodilation	2002
Combination therapy of alpha-glucosidase inhibitor and a sulfonylurea compound prolongs the duration of good glycemic control. Metabolism: clinical and experimental, 2002, Volume: 51, Issue:12 Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Inositol; Male; Middle Aged; Sulfonylurea Compounds; Survival Analysis; Time Factors	2002
Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C. Diabetes technology & therapeutics, 2003, Volume: 5, Issue:1 Topics: Adult; Asian People; Blood Glucose; China; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Environmental Exposure; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Hepatitis B; Hepatitis C; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones	2003
Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Diabetologia, 2004, Volume: 47, Issue:11 Topics: Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Multivariate Analysis; Tunica Intima; Tunica Media	2004
Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients. Clinical physiology and functional imaging, 2005, Volume: 25, Issue:1 Topics: Adult; Analysis of Variance; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Forearm; Gliclazide; Glyburide; Humans; Hyperemia; Hypoglycemic Agents; Ischemia; Male; Middle Aged; Plethysmography; Regional Blood Flow; Time Factors; Vasodilation	2005
Efficacy of glimepiride in Japanese type 2 diabetic subjects. Diabetes research and clinical practice, 2005, Volume: 68, Issue:3 Topics: Aged; Asian People; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Logistic Models; Male; Middle Aged; Obesity; Retreatment; Sulfonylurea Compounds; Treatment Outcome	2005
Secondary sulfonylurea failure: comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide. Diabetes research and clinical practice, 2005, Volume: 70, Issue:3 Topics: Age of Onset; Databases, Factual; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Sulfonylurea Compounds; Time Factors; Treatment Failure	2005
The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:6 Topics: Adult; Aged; Anthropometry; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Monitoring; Female; Gliclazide; Glyburide; Hemoglobins, Abnormal; Humans; Hypoglycemic Agents; Male; Middle Aged; Patient Compliance	2005
Association of gliclazide and left ventricular mass in type 2 diabetic patients. Diabetes research and clinical practice, 2006, Volume: 74, Issue:2 Topics: Aged; Body Mass Index; Diabetes Mellitus, Type 2; Electrocardiography; Female; Gliclazide; Glyburide; Heart Ventricles; Humans; Hypoglycemic Agents; Male; Middle Aged; Oxidative Stress; Prospective Studies; Ventricular Function, Left	2006
Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients. Diabetes & metabolism, 2006, Volume: 32, Issue:4 Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Male; Middle Aged; Reference Values; Vascular Cell Adhesion Molecule-1	2006
Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes. Diabetes, obesity & metabolism, 2007, Volume: 9, Issue:1 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Inflammation; Male; Middle Aged	2007
'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas. Coronary artery disease, 2007, Volume: 18, Issue:6 Topics: Angina Pectoris; Blood Pressure; Diabetes Mellitus, Type 2; Exercise; Gliclazide; Glyburide; Heart Rate; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Sulfonylurea Compounds	2007
Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients. Geriatrics & gerontology international, 2008, Volume: 8, Issue:3 Topics: Aged; Aged, 80 and over; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Treatment Outcome	2008

Other Studies

117 other study(ies) available for gliclazide and glyburide

Article	Year
Novel substituted naphthalen-1-yl-methanone derivatives as anti-hyperglycemic agents. Bioorganic & medicinal chemistry letters, 2006, May-15, Volume: 16, Issue:10 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Naphthalenes; Rats; Rats, Sprague-Dawley; Streptozocin	2006
Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents. Bioorganic & medicinal chemistry, 2008, Mar-01, Volume: 16, Issue:5 Topics: Alkanes; Alkylation; Amination; Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Male; Molecular Structure; Naphthalenes; PPAR gamma; Rats; Structure-Activity Relationship	2008
Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities. European journal of medicinal chemistry, 2009, Volume: 44, Issue:1 Topics: Animals; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Hypoglycemic Agents; Lipids; Mice; Oxazoles; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Structure-Activity Relationship; Triglycerides	2009
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents. Bioorganic & medicinal chemistry, 2009, Jul-15, Volume: 17, Issue:14 Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Hypoglycemic Agents; Hypolipidemic Agents; Isoxazoles; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Sprague-Dawley; Rats, Wistar; Streptozocin; Sucrose; Triglycerides	2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. European journal of medicinal chemistry, 2009, Volume: 44, Issue:11 Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
The direct effect of hypoglycaemic sulphonylureas on myocardial contractile force and arterial blood pressure. Diabetologia, 1977, Volume: 13, Issue:5 Topics: Adrenalectomy; Animals; Blood Pressure; Carbutamide; Cardiac Output; Dogs; Female; Gliclazide; Glyburide; Heart Rate; Hematocrit; Male; Myocardial Contraction; Oxygen; Pancreatectomy; Sulfonylurea Compounds	1977
[Hypoglycemic complications of oral drug therapy of diabetes mellitus. 21 cases]. La Nouvelle presse medicale, 1976, Apr-03, Volume: 5, Issue:14 Topics: Age Factors; Aged; Diabetes Mellitus; Diabetic Coma; Drug Interactions; Female; Gliclazide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney Failure, Chronic; Liver Diseases; Male; Middle Aged; Neurologic Manifestations; Sulfonamides	1976
[The insulin-secreting and proliferative activity of established islet cells in the presence of sulfonylurea]. Biulleten' eksperimental'noi biologii i meditsiny, 1992, Volume: 114, Issue:10 Topics: Animals; Cell Division; Cell Line; Cell Line, Transformed; Cells, Cultured; Cricetinae; Gliclazide; Glyburide; Insulin; Insulin Secretion; Islets of Langerhans; Rats; Sulfonylurea Compounds; Time Factors; Tolbutamide	1992
Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function. Diabetes research and clinical practice, 1992, Volume: 18, Issue:3 Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Gliclazide; Glucagon; Glucose; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Perfusion; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Time Factors; Tolbutamide	1992
Determination of gliclazide in serum by high-performance liquid chromatography using solid-phase extraction. Journal of chromatography, 1992, Dec-02, Volume: 583, Issue:2 Topics: Chromatography, High Pressure Liquid; Gliclazide; Glyburide; Humans; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet	1992
Effects of oral hypoglycaemic agents on platelet functions. Biochemical pharmacology, 1992, Aug-18, Volume: 44, Issue:4 Topics: Arachidonic Acid; Calcium; Dose-Response Relationship, Drug; Fura-2; Gliclazide; Glyburide; Humans; Ionomycin; Platelet Activation; Platelet Aggregation Inhibitors; Sulfonylurea Compounds	1992
Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds. Diabetes research and clinical practice, 1990, Volume: 8, Issue:2 Topics: Animals; Arrhythmias, Cardiac; Blood Glucose; Carbutamide; Dose-Response Relationship, Drug; Electrocardiography; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Male; Myocardial Infarction; Potassium; Rats; Rats, Inbred Strains; Reference Values; Structure-Activity Relationship; Tolbutamide	1990
The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1990, Volume: 22, Issue:1 Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Drug Synergism; Gliclazide; Glucose Tolerance Test; Glyburide; Insulin; Male; Pancreas; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Tolbutamide	1990
A screening test for detecting sulfonylureas in plasma. Therapeutic drug monitoring, 1990, Volume: 12, Issue:4 Topics: Aged; Aged, 80 and over; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds; Tolbutamide	1990
[New oral antidiabetic agents]. Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48 Suppl Topics: Animals; Cyclohexanols; Diabetes Mellitus; Drug Evaluation; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Secretion; Molecular Structure; Pyrrolidines; Stimulation, Chemical; Sulfonylurea Compounds	1990
Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes. Pharmacological research communications, 1986, Volume: 18, Issue:2 Topics: Biological Transport; Calcium; Cell Membrane; Chemical Phenomena; Chemistry, Physical; Gliclazide; Glyburide; Glycerol; Hypoglycemic Agents; In Vitro Techniques; Ionophores; Membrane Lipids; Membranes, Artificial; Protons; Sulfonylurea Compounds	1986
[Hemorheologic, metabolic and blood coagulation changes in diabetics in treatment with sulfanyl ureas]. Minerva medica, 1988, Volume: 79, Issue:5 Topics: Blood Coagulation; Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Deformability; Gliclazide; Glyburide; Humans; Rheology; Sulfonylurea Compounds	1988
Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus. Diabetes research (Edinburgh, Scotland), 1988, Volume: 9, Issue:2 Topics: Aged; Blood Proteins; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Immunoglobulin G; Lipid Peroxides; Male; Platelet Aggregation; Sulfonylurea Compounds; Thromboxane B2	1988
[Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors]. Terapevticheskii arkhiv, 1988, Volume: 60, Issue:12 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Gliclazide; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Hypoglycemic Agents; Insulin; Insulin Antibodies; Insulin Secretion; Leukocytes; Male; Middle Aged; Receptor, Insulin; Sulfonylurea Compounds	1988
Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas. Research communications in chemical pathology and pharmacology, 1985, Volume: 47, Issue:2 Topics: Animals; Calcium; Gliclazide; Glucose; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Ionophores; Keto Acids; Oxidation-Reduction; Rats; Sulfonylurea Compounds; Tolbutamide	1985
Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action. Diabetes research and clinical practice, 1985, Volume: 1, Issue:1 Topics: Acetohexamide; Animals; Buformin; Chlorpropamide; Fructosediphosphates; Gliclazide; Gluconeogenesis; Glyburide; Glycolysis; Hexosediphosphates; In Vitro Techniques; Liver; Male; Rats; Rats, Inbred Strains; Stimulation, Chemical; Sulfamethoxazole; Sulfonylurea Compounds; Tolbutamide	1985
In vitro metabolic effects of gliclazide and glibenclamide in the rat. The Journal of pharmacy and pharmacology, 1980, Volume: 32, Issue:8 Topics: Adipose Tissue; Animals; Gliclazide; Glucose; Glyburide; Glycogen; In Vitro Techniques; Insulin; Male; Metabolism; Muscle, Smooth; Oxidation-Reduction; Rats; Sulfonylurea Compounds	1980
Transport of Pr3+ by hypoglycemic sulfonylureas across liposomal membranes. FEBS letters, 1983, Jan-24, Volume: 151, Issue:2 Topics: Biological Transport; Gliclazide; Glyburide; Ionophores; Kinetics; Liposomes; Magnetic Resonance Spectroscopy; Models, Biological; Molecular Conformation; Praseodymium; Pulmonary Surfactants; Sulfonylurea Compounds	1983
Gliclazide- and glibenclamide-mediated transport of Pr3+ across an artificial lipid membrane. Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 262, Issue:2 Topics: Biological Transport, Active; Gliclazide; Glyburide; Liposomes; Magnetic Resonance Spectroscopy; Membranes, Artificial; Praseodymium; Sulfonylurea Compounds	1983
Preventive and therapeutic effects of gliclazide on diabetic retinopathy: comparison with glibenclamide treatment. The Tohoku journal of experimental medicine, 1983, Volume: 141 Suppl Topics: Adult; Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Gliclazide; Glyburide; Humans; Male; Middle Aged; Platelet Adhesiveness; Sulfonylurea Compounds	1983
[Experience with diamicron treatment of diabetics]. Klinicheskaia meditsina, 1984, Volume: 62, Issue:11 Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Evaluation; Drug Therapy, Combination; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfanilamides; Sulfonylurea Compounds; Time Factors	1984
The inhibition of cancer cell stickiness, a model for investigation of platelet aggregation inhibitors in vivo. Effect of the sulfonyl urea derivatives, glibenclamide, gliclazide, and HB180, as well as the carboxylic acid derivative, meglitinide. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1982, Volume: 180, Issue:1 Topics: Animals; Benzamides; Carcinoma 256, Walker; Cell Aggregation; Diabetes Mellitus; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Platelet Aggregation; Platelet Count; Rats; Rats, Inbred Strains; Sulfonylurea Compounds	1982
Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma. Acta diabetologica, 1995, Volume: 32, Issue:1 Topics: Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Forensic Medicine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Reproducibility of Results; Sensitivity and Specificity; Sulfonylurea Compounds	1995
Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide. Endocrinology, 1995, Volume: 136, Issue:6 Topics: Animals; Biological Transport, Active; Cell Line; Cell Membrane; Cycloheximide; Deoxyglucose; Dose-Response Relationship, Drug; Gliclazide; Glucose; Glyburide; Insulin; Kinetics; Monosaccharide Transport Proteins; Muscle, Skeletal; Rats; Tissue Distribution	1995
Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages. Atherosclerosis, 1994, Volume: 105, Issue:2 Topics: Adult; Animals; Cells, Cultured; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Humans; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Middle Aged; Muscle, Smooth, Vascular; Sulfonylurea Compounds; Tunica Intima	1994
Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:2 Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Biological Transport; Cells, Cultured; Dogs; Gliclazide; Glyburide; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Male; Mice; Mice, Inbred ICR; Microsomes; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Receptors, Drug; Rubidium; Sulfonylurea Receptors	1994
Potentiating effects of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1993, Volume: 25, Issue:2 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Combinations; Drug Synergism; Gliclazide; Glyburide; Hypoglycemic Agents; Rats; Rats, Wistar; Sulfonylurea Compounds; Tolbutamide	1993
[Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1993, Volume: 48 Suppl 1 Topics: Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Sulfonylurea Compounds	1993
Gliclazide hydroxylation by rat liver microsomes. Xenobiotica; the fate of foreign compounds in biological systems, 1995, Volume: 25, Issue:12 Topics: Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gliclazide; Glipizide; Glyburide; Hydroxylation; Hypoglycemic Agents; Kinetics; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Tolbutamide	1995
Cardiovascular effects of conventional sulfonylureas and glimepiride. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9 Topics: Animals; Blood Pressure; Cardiovascular System; Coronary Vessels; Diabetes Mellitus, Experimental; Dogs; Electrocardiography; Female; Gliclazide; Glyburide; Hypoglycemic Agents; Male; Myocardial Ischemia; Potassium Channels; Rats; Rats, Wistar; Sulfonylurea Compounds	1996
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere. Photodermatology, photoimmunology & photomedicine, 1996, Volume: 12, Issue:4 Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E	1996
Inhibitory effect of sulfonylureas on protein phosphatase activity in rat pancreatic islets. Acta diabetologica, 1997, Volume: 34, Issue:1 Topics: Animals; Cytosol; Gliclazide; Glyburide; Hypoglycemic Agents; Islets of Langerhans; Kinetics; Male; Okadaic Acid; Phosphoprotein Phosphatases; Rats; Rats, Wistar; Sulfonylurea Compounds; Tolbutamide	1997
Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction. European journal of pharmacology, 1997, Apr-23, Volume: 325, Issue:1 Topics: Animals; Aorta, Thoracic; Arteries; Bronchi; Cattle; Drug Interactions; Female; Gliclazide; Glyburide; Guinea Pigs; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Prostaglandins; Rats; Rats, Wistar; Species Specificity; Tolazamide; Trachea	1997
Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study. Research communications in molecular pathology and pharmacology, 1997, Volume: 96, Issue:2 Topics: Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Free Radicals; Gliclazide; Glyburide; Hypoglycemic Agents; Nitric Oxide; Oxidative Stress; Superoxides	1997
Rates of hypoglycemia in users of sulfonylureas. Journal of clinical epidemiology, 1997, Volume: 50, Issue:6 Topics: Adult; Aged; Chlorpropamide; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Poisson Distribution; Risk; Risk Factors; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Tolbutamide	1997
Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:10 Topics: Animals; Aorta; Cattle; Cell Adhesion; Cell Survival; Cells, Cultured; Copper Sulfate; Endothelium, Vascular; Gliclazide; Glyburide; Humans; In Vitro Techniques; Lipoproteins, LDL; Monocytes; Oxidation-Reduction; Thiobarbituric Acid Reactive Substances	1997
Effects of glycosylation of hypoglycaemic drug binding to serum albumin. Biopharmaceutics & drug disposition, 1997, Volume: 18, Issue:9 Topics: Acetohexamide; Binding Sites; Binding, Competitive; Gliclazide; Glyburide; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Humans; Hypoglycemic Agents; Metformin; Serum Albumin; Spectrometry, Fluorescence; Structure-Activity Relationship; Tolbutamide	1997
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1 Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Sulfonylurea Compounds; Tolbutamide	1997
Microvascular permeability with sulfonylureas in normal and diabetic hamsters. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1 Topics: Animals; Calcium Channel Blockers; Calcium Channels; Capillary Permeability; Cricetinae; Dextrans; Diabetes Mellitus, Experimental; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Gliclazide; Glyburide; Histamine; Hypoglycemic Agents; Insulin; Macromolecular Substances; Male; Mesocricetus; Nifedipine; Potassium Channels; Reperfusion Injury; Streptozocin; Sulfonylurea Compounds	1997
Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes care, 1998, Volume: 21, Issue:4 Topics: Animals; Aorta; Arteriosclerosis; Cattle; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cytokines; Diabetes Mellitus, Type 2; E-Selectin; Endothelium, Vascular; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Lipid Peroxides; Lipopolysaccharides; Monocytes; Reference Values; Treatment Failure; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	1998
Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel. Biochemical and biophysical research communications, 1999, Apr-21, Volume: 257, Issue:3 Topics: Animals; ATP-Binding Cassette Transporters; Binding Sites; Blotting, Northern; Cell Line; Cell Membrane; COS Cells; Gliclazide; Glipizide; Glyburide; Islets of Langerhans; Kinetics; Organelles; Phentolamine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Recombinant Fusion Proteins; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide; Transfection	1999
The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat. Pharmacological research, 1999, Volume: 39, Issue:5 Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Drug Interactions; Fatty Acids, Nonesterified; Gliclazide; Glucose; Glucose Tolerance Test; Glyburide; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Wistar	1999
Glimepiride: new preparation. Just another hypoglycaemic sulphonylurea agent. Prescrire international, 1998, Volume: 7, Issue:36 Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evaluation; Europe; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Sulfonylurea Compounds; Treatment Outcome; United States	1998
Inhibition of tumor necrosis factor-alpha with anti-diabetic agents. Diabetes research and clinical practice, 1999, Volume: 43, Issue:3 Topics: Animals; Biological Assay; Cells, Cultured; Chromans; Enzyme-Linked Immunosorbent Assay; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Interleukin-1; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1999
Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects. Research communications in molecular pathology and pharmacology, 1999, Volume: 103, Issue:2 Topics: Aged; Female; Gliclazide; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds	1999
Gliclazide scavenges hydroxyl and superoxide radicals: an electron spin resonance study. Metabolism: clinical and experimental, 2000, Volume: 49, Issue:2 Suppl 1 Topics: Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Gliclazide; Glyburide; Hydroxyl Radical; Hypoglycemic Agents; Superoxides	2000
ATP-Sensitive potassium channels modulate glucose transport in cultured human skeletal muscle cells. Endocrine journal, 2001, Volume: 48, Issue:3 Topics: 3-O-Methylglucose; Adenosine Triphosphate; Benzopyrans; Biological Transport; Cells, Cultured; Cyclopentanes; Deoxyglucose; Enzyme Activation; Gliclazide; Glucose; Glyburide; Humans; Hypoglycemic Agents; Insulin; Ion Channel Gating; Muscle, Skeletal; Nicorandil; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Tetradecanoylphorbol Acetate	2001
A novel simple method for the investigation of drug binding to the K(ATP) channel sulfonylurea receptor. Analytical biochemistry, 2002, Aug-15, Volume: 307, Issue:2 Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Gliclazide; Glyburide; Hypoglycemic Agents; Kinetics; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Binding; Rats; Receptors, Drug; Spodoptera; Sulfonylurea Receptors; Tolbutamide	2002
Effects of inhibition of ATP-sensitive potassium channels on metabolic vasodilation in the human forearm. Clinical science (London, England : 1979), 2003, Volume: 104, Issue:1 Topics: Adenosine Triphosphate; Adult; Dose-Response Relationship, Drug; Female; Forearm; Gliclazide; Glyburide; Humans; Hyperemia; Male; Muscle, Skeletal; Plethysmography; Potassium Channel Blockers; Potassium Channels; Regional Blood Flow; Vasodilation	2003
Differential effects of sulphonylureas on the vasodilatory response evoked by K(ATP) channel openers. Fundamental & clinical pharmacology, 2003, Volume: 17, Issue:1 Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Cricetinae; Cromakalim; Diazoxide; Drug Interactions; Gliclazide; Glyburide; Guinea Pigs; Hypoglycemic Agents; In Vitro Techniques; Ion Channel Gating; Male; Potassium Channels; Rats; Rats, Wistar; Species Specificity; Sulfonylurea Compounds; Vasodilation; Vasodilator Agents	2003
Urinary PC-1 and N-acetyl-beta-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide. Annals of clinical biochemistry, 2003, Volume: 40, Issue:Pt 3 Topics: Acetylglucosaminidase; Administration, Oral; Adult; Aged; Creatinine; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Obesity; Phosphoric Diester Hydrolases; Pyrophosphatases	2003
Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet. Kidney international, 2004, Volume: 65, Issue:3 Topics: Animals; Blood Pressure; Cholesterol, Dietary; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Free Radical Scavengers; Gliclazide; Glyburide; Glycated Hemoglobin; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Kidney; Macrophages; Male; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase	2004
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes research and clinical practice, 2004, Volume: 64, Issue:3 Topics: Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diet Therapy; Drug Administration Schedule; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Japan; Male; Metformin; Middle Aged; Prospective Studies; Sulfonylurea Compounds; Time Factors; Tunica Intima; Tunica Media	2004
Octreotide treatment for sulfonylurea-induced hypoglycaemia. The Medical journal of Australia, 2004, May-17, Volume: 180, Issue:10 Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Octreotide; Sulfonylurea Compounds; Treatment Outcome	2004
Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide. Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Gliclazide; Glyburide; Hypoglycemic Agents; Ischemic Preconditioning; Male; Membrane Potentials; Mitochondria, Heart; Myocardial Infarction; Nicorandil; Rats; Rats, Sprague-Dawley	2004
Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes. Biochemical pharmacology, 2004, Sep-01, Volume: 68, Issue:5 Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Drug Interactions; Female; Gene Expression; Gliclazide; Glyburide; Hypoglycemic Agents; Membrane Proteins; Mice; Oocytes; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Subunits; Rats; Receptors, Drug; Sulfonylurea Receptors; Taurine; Tolbutamide; Xenopus laevis	2004
The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Mar-25, Volume: 817, Issue:2 Topics: Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metformin; Reference Standards; Sensitivity and Specificity	2005
The effect of gliclazide and glibenclamide on preconditioning of the human myocardium. European journal of pharmacology, 2005, May-16, Volume: 515, Issue:1-3 Topics: Algorithms; Atrial Appendage; Creatine Kinase; Dose-Response Relationship, Drug; Enzyme Activation; Gliclazide; Glyburide; Heart; Humans; Hypoglycemic Agents; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Muscle, Smooth, Vascular; Myocardium; p38 Mitogen-Activated Protein Kinases; Potassium Channels; Protein Kinase C; Signal Transduction	2005
Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocin-induced diabetes. Current eye research, 2005, Volume: 30, Issue:9 Topics: Aniline Compounds; Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gliclazide; Glyburide; Hypoglycemic Agents; Ionomycin; Ionophores; Ischemia; Microscopy, Confocal; Rats; Rats, Sprague-Dawley; Retina; Streptozocin; Xanthenes	2005
Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human p Biomedical chromatography : BMC, 2006, Volume: 20, Issue:10 Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Pioglitazone; Piperidines; Reproducibility of Results; Rosiglitazone; Thiazolidinediones	2006
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose. Diabetes/metabolism research and reviews, 2007, Volume: 23, Issue:3 Topics: Antioxidants; Apoptosis; Cells, Cultured; Female; Gliclazide; Glucose; Glyburide; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Microscopy, Electron; Middle Aged; Tyrosine	2007
Actions of ZD0947, a novel ATP-sensitive K+ channel opener, on membrane currents in human detrusor myocytes. British journal of pharmacology, 2006, Volume: 149, Issue:5 Topics: ATP-Binding Cassette Transporters; Carbachol; Diazoxide; Dihydropyridines; Dose-Response Relationship, Drug; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gliclazide; Glyburide; Humans; Immunochemistry; In Vitro Techniques; Membrane Potentials; Muscle Relaxation; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Pinacidil; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors; Urinary Bladder	2006
Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality. Diabetes/metabolism research and reviews, 2007, Volume: 23, Issue:6 Topics: Aged; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gliclazide; Glyburide; Heart Diseases; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Neoplasms; Retrospective Studies; Sulfonylurea Compounds	2007
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Jun-15, Volume: 853, Issue:1-2 Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Molecular Structure; Piperidines; Reproducibility of Results; Sulfonylurea Compounds	2007
Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization. Free radical biology & medicine, 2007, Aug-01, Volume: 43, Issue:3 Topics: Acetylcysteine; Animals; Blood Glucose; Female; Gliclazide; Glyburide; Ischemia; Mice; Oxidative Stress; Oxygen; Retina; Retinal Neovascularization; RNA, Messenger; Sulfonylurea Compounds; Vascular Endothelial Growth Factor A	2007
Gliclazide inhibits proliferation but stimulates differentiation of white and brown adipocytes. Journal of biochemistry, 2007, Volume: 142, Issue:5 Topics: Adipocytes, Brown; Adipocytes, White; Animals; Blotting, Western; Cell Differentiation; Cell Line; Cell Proliferation; Diazoxide; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Gliclazide; Glyburide; Hypoglycemic Agents; Mice; Phosphorylation; PPAR gamma; Signal Transduction; Sulfonylurea Compounds	2007
Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2007, Volume: 22, Issue:3 Topics: Animals; Gliclazide; Glyburide; Heart; Ischemic Preconditioning; Male; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds	2007
Spermicidal activity of sulfonylureas and meglitinide analogues: role of intrasperm Ca2+ elevation. The Journal of pharmacy and pharmacology, 2008, Volume: 60, Issue:3 Topics: Adult; Benzamides; Calcium; Carbamates; Cross-Over Studies; Dose-Response Relationship, Drug; Gliclazide; Glyburide; Homeostasis; Humans; Hypoglycemic Agents; KATP Channels; Male; Piperidines; Sperm Motility; Spermatocidal Agents; Spermatozoa; Sulfonylurea Compounds; Time Factors	2008
Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6. Metabolism: clinical and experimental, 2008, Volume: 57, Issue:8 Topics: Animals; Apoptosis; Cell Line; Cyclohexanes; Fluoresceins; Gliclazide; Glyburide; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; NADPH Oxidases; Nateglinide; Phenylalanine; Protein Kinase C; Reactive Oxygen Species; Sulfonylurea Compounds	2008
Sulphonylureas and cancer: a case-control study. Acta diabetologica, 2009, Volume: 46, Issue:4 Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Neoplasms; Risk Factors; Sulfonylurea Compounds	2009
Second-generation sulfonylureas preserve inhibition of mitochondrial permeability transition by the mitochondrial K+(ATP) opener nicorandil in experimental myocardial infarction. Shock (Augusta, Ga.), 2009, Volume: 32, Issue:3 Topics: Animals; Calcium; Gliclazide; Glyburide; Hemodynamics; Male; Mitochondria; Myocardial Infarction; Nicorandil; Potassium Channel Blockers; Potassium Channels; Rabbits; Sulfonylurea Compounds	2009
Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice. Metabolism: clinical and experimental, 2009, Volume: 58, Issue:3 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Gliclazide; Glucagon-Like Peptide 1; Glucose Intolerance; Glyburide; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred ICR; Niacinamide; Piperidines; Pyrrolidines; Sulfonylurea Compounds	2009
Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide. Diabetes & metabolism, 2009, Volume: 35, Issue:4 Topics: Aged; Analysis of Variance; Cells, Cultured; Female; Gliclazide; Glucose; Glyburide; Homeodomain Proteins; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Ki-67 Antigen; Male; Middle Aged; Pancreas; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Donors; Trans-Activators	2009
Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study. Diabetes research and clinical practice, 2009, Volume: 86, Issue:3 Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Middle Aged; Patient Selection; Proportional Hazards Models; Risk Factors; Sulfonylurea Compounds; Ukraine	2009
Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs. Journal of pharmaceutical and biomedical analysis, 2010, Mar-11, Volume: 51, Issue:4 Topics: Aerosols; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Light; Reproducibility of Results; Scattering, Radiation; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds	2010
Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus. Metabolism: clinical and experimental, 2010, Volume: 59, Issue:9 Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Azides; Blood Glucose; Body Mass Index; Deoxyuracil Nucleotides; Diabetes Mellitus, Type 2; Female; Fibrinolysin; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Aggregation	2010
Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients. Endocrine journal, 2010, Volume: 57, Issue:6 Topics: Aged; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Family Practice; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Middle Aged; Practice Patterns, Physicians'; Sulfonylurea Compounds; Treatment Outcome	2010
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry. Diabetes research and clinical practice, 2010, Volume: 90, Issue:3 Topics: Aged; Asian People; Cohort Studies; Diabetes Mellitus, Type 2; Female; Gliclazide; Glipizide; Glyburide; Hong Kong; Humans; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prospective Studies; Registries; Risk Factors; Sulfonylurea Compounds	2010
Comparison of two sulfonylureas with high and low myocardial K(ATP) channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes. Diabetologia, 2011, Volume: 54, Issue:2 Topics: Animals; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Glycogen; Lactic Acid; Male; Myocardial Infarction; Myocardium; Potassium Channels; Rats; Rats, Wistar; Sulfonylurea Compounds	2011
Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A. Pharmacogenetics and genomics, 2012, Volume: 22, Issue:3 Topics: ATP-Binding Cassette Transporters; Chlorpropamide; Cyclohexanes; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gliclazide; Glyburide; Haplotypes; Homozygote; Humans; Isoindoles; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Polymorphism, Single Nucleotide; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide	2012
Glycaemic control and cost analysis when changing from gliclazide co-administered with metformin to pre-combined glibenclamide-metformin tablets in type 2 diabetes mellitus. The Medical journal of Malaysia, 2012, Volume: 67, Issue:1 Topics: Blood Glucose; Costs and Cost Analysis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Retrospective Studies; Tablets	2012
Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death. Basic & clinical pharmacology & toxicology, 2012, Volume: 111, Issue:4 Topics: Animals; Cell Death; Cell Line; Cluster Analysis; Diabetes Mellitus, Type 2; Gene Regulatory Networks; Gliclazide; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Microarray Analysis; Rats; Sulfonylurea Compounds; Up-Regulation	2012
Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Incidence; Ischemic Preconditioning; Male; Myocardial Infarction; Myocardium; Ontario; Risk Factors; Sulfonylurea Compounds; Treatment Outcome	2012
Rapid extraction, identification and quantification of oral hypoglycaemic drugs in serum and hair using LC-MS/MS. Forensic science international, 2012, Nov-30, Volume: 223, Issue:1-3 Topics: Acetonitriles; Chromatography, Liquid; Female; Forensic Toxicology; Gliclazide; Glipizide; Glyburide; Hair; Humans; Hypoglycemic Agents; Limit of Detection; Male; Mass Spectrometry; Metformin; Methanol; Middle Aged; Molecular Structure; Solvents; Sulfonylurea Compounds	2012
Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients. European journal of endocrinology, 2013, Volume: 169, Issue:1 Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confounding Factors, Epidemiologic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Neoplasms; Odds Ratio; Proportional Hazards Models; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Sulfonylurea Compounds; Tolbutamide	2013
Effects of a sitagliptin safety alert on prescription behaviour for oral antihyperglycaemic drugs: a propensity score-matched cohort study of prescription receipt data in Japan. Drug safety, 2013, Volume: 36, Issue:8 Topics: Aged; Cohort Studies; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Japan; Logistic Models; Male; Middle Aged; Patient Safety; Practice Patterns, Physicians'; Propensity Score; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles	2013
Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study. Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:1 Topics: Acute Coronary Syndrome; Aged; Alberta; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Odds Ratio; Risk Assessment; Risk Factors; Sulfonylurea Compounds; Treatment Outcome	2014
Evaluation approach can significantly influence oral glucose-lowering drugs total mortality risks in retrospective cohorts of type 2 diabetes mellitus patients. Current diabetes reviews, 2014, Volume: 10, Issue:5 Topics: Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Metformin; Registries; Retrospective Studies; Risk Factors; Treatment Outcome; Ukraine	2014
Fast and Simultaneous Analysis of Combined Anti-Diabetic Drugs by Capillary Zone Electrophoresis. Journal of chromatographic science, 2015, Volume: 53, Issue:6 Topics: Drug Combinations; Electrophoresis, Capillary; Gliclazide; Glyburide; Hypoglycemic Agents; Limit of Detection; Linear Models; Metformin; Reproducibility of Results; Tablets	2015
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study. Diabetes research and clinical practice, 2015, Volume: 107, Issue:1 Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Morbidity; Myocardial Infarction; Piperidines; Registries; Retrospective Studies; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide	2015
Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study. Journal of diabetes and its complications, 2015, Volume: 29, Issue:2 Topics: Aged; Aged, 80 and over; Alberta; Blue Cross Blue Shield Insurance Plans; Carbamates; Cardiovascular Diseases; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Female; Gliclazide; Glyburide; Hospitalization; Humans; Hypoglycemic Agents; Male; Myocardial Ischemia; Piperidines; Proportional Hazards Models; Retrospective Studies; Risk; Universal Health Insurance	2015
The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide. Canadian journal of diabetes, 2015, Volume: 39, Issue:4 Topics: Aged; Aged, 80 and over; Cohort Studies; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Ontario; Population Surveillance; Retrospective Studies; Risk Factors	2015
Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes. Pharmacoepidemiology and drug safety, 2016, Volume: 25, Issue:10 Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Male; Propensity Score; Proportional Hazards Models; Retrospective Studies; Sulfonylurea Compounds; Time Factors	2016
[Effects of different sulfonylureas on the warm-up phenomenon in diabetes patients with coronary artery disease]. Zhonghua yi xue za zhi, 2017, Jan-17, Volume: 97, Issue:3 Topics: Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Electrocardiography; Exercise Test; Gliclazide; Glyburide; Humans; Hypoglycemic Agents	2017
Binding of sulphonylureas to plasma proteins - A KATP channel perspective. PloS one, 2018, Volume: 13, Issue:5 Topics: Animals; Cattle; Cells, Cultured; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; KATP Channels; Mice; Mice, Inbred C57BL; Oocytes; Patch-Clamp Techniques; Protein Binding; Recombinant Proteins; Serum Albumin; Serum Albumin, Bovine; Xenopus laevis	2018
Different sulfonylureas induce the apoptosis of proximal tubular epithelial cell differently via closing K Molecular medicine (Cambridge, Mass.), 2018, 09-04, Volume: 24, Issue:1 Topics: Apoptosis; Cell Line; Epithelial Cells; Gliclazide; Glyburide; Humans; KATP Channels; Kidney Tubules, Proximal; Sulfonylurea Compounds	2018
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis. Diabetes research and clinical practice, 2019, Volume: 152 Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Mortality; Piperidines; Secretagogues; Sulfonylurea Compounds; Taiwan	2019
Effect of berberine on in vitro metabolism of sulfonylureas: A herb-drug interactions study. Rapid communications in mass spectrometry : RCM, 2020, Volume: 34 Suppl 4 Topics: Animals; Berberine; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Female; Gliclazide; Glyburide; Herb-Drug Interactions; Male; Mass Spectrometry; Microsomes, Liver; Rats; Sulfonylurea Compounds	2020
The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy. Vascular health and risk management, 2020, Volume: 16 Topics: Biomarkers; Blood Glucose; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Gene Frequency; Gliclazide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Pharmacogenomic Variants; Risk Factors; Treatment Outcome	2020
Studies of binding by sulfonylureas with glyoxal- and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns. Journal of chromatography. A, 2021, Feb-08, Volume: 1638 Topics: Adsorption; Antibodies; Chromatography, Affinity; Drug Interactions; Gliclazide; Glyburide; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; Kinetics; Protein Binding; Protein Stability; Pyruvaldehyde; Serum Albumin, Human; Sulfonylurea Compounds; Warfarin	2021
Sensitive detection of antidiabetic compounds and one degradation product in wastewater samples by a new SPE-LC-MS/MS method. Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, 2021, Volume: 56, Issue:3 Topics: Chromatography, Liquid; Environmental Monitoring; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Metformin; Reproducibility of Results; Solid Phase Extraction; Sulfonylurea Compounds; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical	2021
Crude extract from Journal of complementary & integrative medicine, 2023, Jun-01, Volume: 20, Issue:2 Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Euphorbia; Gliclazide; Glyburide; Hypoglycemic Agents; Insulin; Metformin; Plant Extracts; Rats	2023
Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Journal of pharmaceutical sciences, 2023, Volume: 112, Issue:5 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Metformin; Nitrosamines; Pharmaceutical Preparations; Tandem Mass Spectrometry	2023
[Characteristics of purchases of hypoglycemic agents in pharmacy retail sector in 2016-2020 years dynamics]. Problemy endokrinologii, 2023, 08-30, Volume: 69, Issue:4 Topics: Dipeptidyl Peptidase 4; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Metformin; Pharmacies; Pharmacy	2023
Hyperpolarisation of rat mesenteric endothelial cells by ATP-sensitive K(+) channel openers. European journal of pharmacology, 2000, Jun-02, Volume: 397, Issue:2-3 Topics: Adenosine Triphosphate; Animals; Apamin; Barium Compounds; Benzimidazoles; Carbachol; Charybdotoxin; Chlorides; Cromakalim; Dose-Response Relationship, Drug; Electrophysiology; Endothelium, Vascular; Glyburide; Glycyrrhetinic Acid; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Ouabain; Potassium Channels; Rats; Rats, Wistar; Vasodilator Agents	2000
Endothelium-derived relaxing factor-mediated vasodilation in mouse mesenteric vascular beds. Journal of pharmacological sciences, 2012, Volume: 118, Issue:3 Topics: Acetylcholine; Animals; Biological Factors; Calcimycin; Calcium Ionophores; Cyclooxygenase Inhibitors; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Enzyme Inhibitors; Gap Junctions; Glyburide; Glycyrrhetinic Acid; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Potassium Channel Blockers; Tetraethylammonium; Vasodilation; Vasodilator Agents	2012